Physician profile
James Smith
NPI 1750676524
$5,948.55
in general payments reported to CMS, 2019-2025
24 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $259 · 2021: $1,441 · 2022: $1,732 · 2023: $1,058 · 2024: $493 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,656 · Travel and Lodging: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.04 |
| Travel and Lodging | $518.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,871.41 | 2021-2025 | Excelsiusgps Robotic Navigation System, Sable, Altera |
| Boston Scientific Corporation | $1,190.11 | 2020-2025 | General - Pain Management |
| Stryker Corporation | $385.61 | 2019-2025 | Adherus Autospray Dural Sealant, Clottriever Bold Catheter |
| Si-Bone, INC. | $372.98 | 2022-2023 | |
| Medtronic, INC. | $353.72 | 2022-2024 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Arteriocyte Medical Systems, INC. | $231.34 | 2025 | Magellan |
| Medical Device Business Services, INC. | $93.06 | 2019 | |
| Depuy Synthes Sales INC. | $52.01 | 2019 | |
| Lemaitre Vascular, INC. | $46.71 | 2019 | |
| Nuvasive, INC. | $45.20 | 2020 | |
| Dexcom, INC. | $38.93 | 2021-2023 | Dexcom G6 Transmitter |
| Mallinckrodt Enterprises LLC | $29.49 | 2019 | |
| Abbott Laboratories | $27.56 | 2019 | |
| Medtronic USA, INC. | $25.97 | 2019-2020 | |
| Djo, LLC | $24.59 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $23.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.62 | 2020 | |
| Emd Serono, INC. | $18.99 | 2019 | |
| Viz.Ai, INC. | $18.45 | 2022 | |
| Sanara Medtech INC. | $18.06 | 2022 | |
| Convatec INC. | $17.78 | 2020 | |
| Integra Lifesciences Corporation | $17.13 | 2021 | |
| Merz North America, INC. | $14.77 | 2019 | |
| Ucb, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.